Capper Joseph H 4
4 · MIMEDX GROUP, INC. · Filed Mar 6, 2026
Research Summary
AI-generated summary of this filing
MiMedx (MDXG) CEO Joseph Capper Receives Restricted Stock Award
What Happened
Joseph H. Capper, CEO of MiMedx Group, Inc. (MDXG), received equity awards reported on 2026-03-04: 371,094 shares were granted as restricted stock (acquired at $0) and an additional 310,574 derivative shares (acquired at $0). These were reported on a Form 4 filed 2026-03-06. These are awards/compensation — not open-market purchases or sales — and no cash changed hands at grant.
Key Details
- Transaction date: March 4, 2026; Form 4 filed March 6, 2026 (reporting period: 2026-03-04). Filing appears timely.
- Grants: 371,094 restricted shares @ $0.00 (award); 310,574 derivative shares @ $0.00 (award/derivative). Total shares granted on that date = 681,668.
- Vesting and related footnotes:
- F1: The 371,094 restricted shares vest in full on the third anniversary of the grant, subject to continued employment.
- F3: (Referenced) options generally vest 25% each year on anniversaries if and when option grants apply.
- F2: Separately notes an aggregate of 4,032 shares previously acquired (July 31, 2025 and Jan 30, 2026) under the company Employee Stock Purchase Plan.
- Shares owned after transaction: not specified in the provided filing summary.
- No sales, option exercises for cashless sale, or tax-withholding sales were reported in this filing.
Context
These awards are typical executive compensation/retention grants. Because the restricted/derivative shares vest over time, they are not immediately tradable and do not represent an immediate market purchase or sale. Awards at $0 reflect compensation value at grant rather than a cash investment by the insider; they should be viewed as part of pay and retention rather than an explicit personal buy/sell signal.
Insider Transaction Report
- Award
Common Stock
[F1][F2]2026-03-04+371,094→ 904,656 total - Award
Stock Options
[F3]2026-03-04+310,574→ 4,087,938 totalExercise: $5.10Exp: 2033-03-03→ Common Stock (310,574 underlying)
Footnotes (3)
- [F1]Represents grant of restricted stock which vests fully on the third anniversary of the grant, subject to the reporting person's continued employment as specified in the Restricted Stock Unit Agreement.
- [F2]Includes an aggregate of 4,032 shares acquired on July 31, 2025 and January 30, 2026 pursuant to the MiMedx Group, Inc. Employee Stock Purchase Plan.
- [F3]The options granted to the reporting person shall vest 25% on each anniversary of the grant date, subject to the reporting person's continued employment as specified in the Nonqualified Stock Option Agreement.